The Department of Defense's Defense Health Agency awarded a $1,500,000 Project Grant to the Regents of the University of Michigan to develop "Regenerative Peripheral Nerve Interfaces to Enhance Function and Sensation in People with Transfemoral Amputation" over 4 years, from September 1, 2023 to August 31, 2027. This grant is funded through the Military Medical Research and Development program (CFDA 12.420), which supports biomedical research to transform healthcare for Service Members...
This Project Grant from the Defense Health Agency provides $8,351,133 to the Regents of the University of Michigan from May 1, 2023 to April 30, 2027. The grant supports research under the Military Medical Research and Development program (CFDA 12.420) to investigate the pivotal and diverse roles of matricellular proteins in musculoskeletal disorders. The University of Michigan will conduct the primary research. Two subawards totaling $XXX,XXX were also issued to support complementary work....
The Regents of the University of Michigan received a $312,000.00 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The 2-year grant, awarded on February 1, 2024, supports research to investigate "An Unexpected Role for the Ubiquitin Proteasome System in Repeat Associated Non-AUG Translation." This basic and translational biomedical research aims to advance understanding and treatment of neurological disorders...
This $1,499,872 federal Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports the development of an exoskeleton-integrated boot system to facilitate rehabilitation and return to duty for military personnel with lateral ankle sprains. The primary awardee, Results Group, LLC, is a small disadvantaged business specializing in advanced assistive technologies and rehabilitation devices. The funding will enable Results Group to...
This $932,498 project grant, awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports research to develop a non-invasive central nervous system (CNS) delivery method for immunocytokines to expand regulatory T cells (Tregs) and treat amyotrophic lateral sclerosis (ALS). The Regents of the University of Michigan, a prominent U.S. state government-owned educational institution, will conduct this cutting-edge biomedical research over...
The University of Michigan will receive $725,000 under a three-year Project Grant award from the Department of the Army Medical Command's Military Medical Research and Development program. The grant will fund research to develop an angiogenic therapy to enhance and accelerate repair of traumatic bone defects. The University's Office of Research and Sponsored Projects will oversee delivery of the research services from September 1, 2022 through August 31, 2025 at their Ann Arbor, Michigan...
The Defense Health Agency awarded a $1,493,220 Project Grant to The Cleveland VA Medical Research & Education Foundation under the Military Medical Research and Development program (CFDA 12.420). The grant supports the development of a "Neurally Integrated Lower Limb Prosthesis for Home and Community Use" to aid mobility and sensory restoration for wounded veterans. The 4-year project, running from September 2023 to August 2027, aligns with the program's priorities of advancing...
This $1,971,886 project grant from the Department of the Army Medical Command, under the Military Medical Research and Development program (CFDA 12.420), supports research exploring the impact of microprocessor-controlled knees on prosthesis awareness and overall health. Virginia Commonwealth University is the primary awardee and will work with sub-awardees Hanger, Inc. and the University of Washington on this research from July 2021 through June 2025. The grant aims to transform military and...
The University of Michigan will receive $304,472 over two years through a Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program. The grant will fund research into regulating prostate skeletal bone metastases through TIM-3-dependent efferocytosis. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public health care through innovative and...
The University of Texas Health Science Center at Houston was awarded a $1,498,514 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program. The grant will fund research from September 2022 through September 2026 to improve functional performance in transfemoral amputees through somatosensory augmentation. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of...